Basic Information
| LncRNA/CircRNA Name | FER1L4 |
| Synonyms | FER1L4, C20orf124 |
| Region | GRCh38_20:35558737-35607562 |
| Ensemble | ENSG00000088340 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | endometrial cancer |
| ICD-0-3 | NA |
| Methods | qPCR, etc. |
| Sample | EC tissues |
| Expression Pattern | down-regulated |
| Function Description | FER1L4 in EC tissues was significantly down-regulated compared with adjacent non-tumor tissues (p<0.01). |
| Pubmed ID | 30556848 |
| Year | 2018 |
| Title | Overexpression of LncRNA FER1L4 in endometrial carcinoma is associated with favorable survival outcome |
External Links
| Links for FER1L4 | GenBank HGNC NONCODE |
| Links for endometrial cancer | OMIM COSMIC |